Entrada Therapeutics Inc.

NASDAQ: TRDA · Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT

Entrada Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
210.78M 129.01M n/a n/a
Cost of Revenue
n/a 99.88M 1.9M 1.12M
Gross Profit
210.78M 29.13M -1.9M -1.12M
Operating Income
47.01M -3.16M -97.25M -51.13M
Interest Income
19.47M 15.22M 2.63M n/a
Pretax Income
66.48M 12.06M -94.62M -51.16M
Net Income
65.63M -6.68M -87.46M -50.07M
Selling & General & Admin
38.47M 32.29M 30.64M 15.2M
Research & Development
125.31M 99.88M 66.61M 35.93M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
163.77M 132.18M 97.25M 51.13M
Interest Expense
n/a n/a 2.63M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
163.77M 132.18M 97.25M 51.13M
Income Tax Expense
859K 18.74M -7.16M -1.09M
Shares Outstanding (Basic)
37.31M 33.05M 31.29M 31.22M
Shares Outstanding (Diluted)
39M 33.05M 31.29M 31.22M
EPS (Basic)
1.76 -0.2 -2.79 -1.6
EPS (Diluted)
1.68 -0.2 -2.79 -1.6
EBITDA
47.01M -321K -95.35M -50.01M
EBIT
47.01M -3.16M -97.25M -51.16M
Depreciation & Amortization
n/a 2.84M 1.9M 1.12M